» Articles » PMID: 38114489

High-throughput Deconvolution of 3D Organoid Dynamics at Cellular Resolution for Cancer Pharmacology with Cellos

Overview
Journal Nat Commun
Specialty Biology
Date 2023 Dec 19
PMID 38114489
Authors
Affiliations
Soon will be listed here.
Abstract

Three-dimensional (3D) organoid cultures are flexible systems to interrogate cellular growth, morphology, multicellular spatial architecture, and cellular interactions in response to treatment. However, computational methods for analysis of 3D organoids with sufficiently high-throughput and cellular resolution are needed. Here we report Cellos, an accurate, high-throughput pipeline for 3D organoid segmentation using classical algorithms and nuclear segmentation using a trained Stardist-3D convolutional neural network. To evaluate Cellos, we analyze ~100,000 organoids with ~2.35 million cells from multiple treatment experiments. Cellos segments dye-stained or fluorescently-labeled nuclei and accurately distinguishes distinct labeled cell populations within organoids. Cellos can recapitulate traditional luminescence-based drug response of cells with complex drug sensitivities, while also quantifying changes in organoid and nuclear morphologies caused by treatment as well as cell-cell spatial relationships that reflect ecological affinity. Cellos provides powerful tools to perform high-throughput analysis for pharmacological testing and biological investigation of organoids based on 3D imaging.

Citing Articles

Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids.

Lederer A, Gorrissen N, Nguyen T, Kreutz C, Rasel H, Bartsch F J Transl Med. 2025; 23(1):34.

PMID: 39789543 PMC: 11716211. DOI: 10.1186/s12967-024-06012-x.


A spheroid whole mount drug testing pipeline with machine-learning based image analysis identifies cell-type specific differences in drug efficacy on a single-cell level.

Vitacolonna M, Bruch R, Schneider R, Jabs J, Hafner M, Reischl M BMC Cancer. 2024; 24(1):1542.

PMID: 39696122 PMC: 11658419. DOI: 10.1186/s12885-024-13329-9.


Advancing cancer research through organoid technology.

Zeng G, Yu Y, Wang M, Liu J, He G, Yu S J Transl Med. 2024; 22(1):1007.

PMID: 39516934 PMC: 11545094. DOI: 10.1186/s12967-024-05824-1.


Understanding patient-derived tumor organoid growth through an integrated imaging and mathematical modeling framework.

Gunnarsson E, Kim S, Choi B, Schmid J, Kaura K, Lenz H PLoS Comput Biol. 2024; 20(8):e1012256.

PMID: 39093897 PMC: 11324155. DOI: 10.1371/journal.pcbi.1012256.


A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine.

Kalla J, Pfneissl J, Mair T, Tran L, Egger G Cell Oncol (Dordr). 2024; 48(1):1-26.

PMID: 38806997 PMC: 11850459. DOI: 10.1007/s13402-024-00960-8.


References
1.
Langhans S . Using 3D in vitro cell culture models in anti-cancer drug discovery. Expert Opin Drug Discov. 2021; 16(8):841-850. DOI: 10.1080/17460441.2021.1912731. View

2.
Jensen C, Teng Y . Is It Time to Start Transitioning From 2D to 3D Cell Culture?. Front Mol Biosci. 2020; 7:33. PMC: 7067892. DOI: 10.3389/fmolb.2020.00033. View

3.
Zhang L, Wang L, Yang S, He K, Bao D, Xu M . Quantifying the drug response of patient-derived organoid clusters by aggregated morphological indicators with multi-parameters based on optical coherence tomography. Biomed Opt Express. 2023; 14(4):1703-1717. PMC: 10110317. DOI: 10.1364/BOE.486666. View

4.
Filippi-Chiela E, Oliveira M, Jurkovski B, Callegari-Jacques S, da Silva V, Lenz G . Nuclear morphometric analysis (NMA): screening of senescence, apoptosis and nuclear irregularities. PLoS One. 2012; 7(8):e42522. PMC: 3414464. DOI: 10.1371/journal.pone.0042522. View

5.
van der Walt S, Schonberger J, Nunez-Iglesias J, Boulogne F, Warner J, Yager N . scikit-image: image processing in Python. PeerJ. 2014; 2:e453. PMC: 4081273. DOI: 10.7717/peerj.453. View